In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices
Categories:
Uncategorized
Related Post
Would Anyone Use a Chinese Stablecoin?Would Anyone Use a Chinese Stablecoin?
[A new law in Hong Kong could pave the way for digital currencies tied to China.
Asia Cup Super 4s decided as road to FIH WC beginsAsia Cup Super 4s decided as road to FIH WC begins
The semifinalist were confirmed on day four of the Hero Asia Cup Rajgir, Bihar 2025. The last round of pool matches produced a thrilling mix of high-scoring clashes. Fans were
Body reviews Chinese projectsBody reviews Chinese projects
In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has aggressively blocked competition for it.